Literature DB >> 4138943

Methemoglobin reductase (cytochrome b5 reductase) deficiency in congenital methemoglobinemia.

T Kitao, Y Sugita, Y Yoneyama, K Hattori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4138943

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b5 Reductase 3 That Increase Nitric Oxide Bioavailability.

Authors:  Md Mizanur Rahaman; Fabio G Reinders; David Koes; Anh T Nguyen; Stephanie M Mutchler; Courtney Sparacino-Watkins; Roger A Alvarez; Megan P Miller; Dongmei Cheng; Bill B Chen; Edwin K Jackson; Carlos J Camacho; Adam C Straub
Journal:  J Biol Chem       Date:  2015-05-22       Impact factor: 5.157

2.  Crystal structures of the naturally fused CS and cytochrome b5 reductase (b5R) domains of Ncb5or reveal an expanded CS fold, extensive CS-b5R interactions and productive binding of the NAD(P)+ nicotinamide ring.

Authors:  David R Benson; Scott Lovell; Nurjahan Mehzabeen; Nadezhda Galeva; Anne Cooper; Philip Gao; Kevin P Battaile; Hao Zhu
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-06-26       Impact factor: 7.652

3.  Isolated Diaphorase From Bovine Erythrocyte Cannot Reduce Oxidized Cytoglobin (Metcygb).

Authors:  Gissi Novientri; Mohamad Sadikin; Sri Widia Jusman
Journal:  Rep Biochem Mol Biol       Date:  2022-07

4.  Methemoglobinemia in a young man.

Authors:  Yasmin S Hamirani; Wayne Franklin; Ronald G Grifka; Raymond F Stainback
Journal:  Tex Heart Inst J       Date:  2008

5.  Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.

Authors:  Kristina L Blanke; James C Sacco; Robert C Millikan; Andrew F Olshan; Jingchun Luo; Lauren A Trepanier
Journal:  Cancer Causes Control       Date:  2014-09-16       Impact factor: 2.506

6.  Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

Authors:  James C Sacco; Mahmoud Abouraya; Alison Motsinger-Reif; Steven H Yale; Catherine A McCarty; Lauren A Trepanier
Journal:  Pharmacogenet Genomics       Date:  2012-10       Impact factor: 2.089

7.  Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation.

Authors:  M Takeshita; T Matsuki; K Tanishima; T Yubisui; Y Yoneyama; K Kurata; N Hara; T Igarashi
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

8.  Congenital methemoglobinemia in a dog with a promoter deletion and a nonsynonymous coding variant in the gene encoding cytochrome b₅.

Authors:  J A McKenna; J Sacco; T T Son; L A Trepanier; M B Callan; J W Harvey; J W Arndt
Journal:  J Vet Intern Med       Date:  2014-08-21       Impact factor: 3.333

9.  Congenital methemoglobinemia misdiagnosed as polycythemia vera: Case report and review of literature.

Authors:  Dina Sameh Soliman; Mohamed Yassin
Journal:  Hematol Rep       Date:  2018-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.